6[1]Seidenman P.Methotrexate-the relationship between dose and clinical effect[J].Br J Rheumatol,1993,32(8):751 被引量：1
7[2]Albertioni F,Rask C,Eksborg S,et al.Evaluation of clinical assays for measuring high-dose methotrexate in plasma[J].Clinical Chemistry.1996,42(1):39 被引量：1
8[3]Treon SP,Chabner BA.Concepts in use of high-dose methotrexate therapy[J].Clinical Chemistry,1996,42(pt2):1322-1329 被引量：1
9[4]Grigg A.Folic Acid rescue after methotrexate[J].Bone Marrow Transplant.1993,11(3):1251 被引量：1
10[5]Bagarry-Liegey D,Nicoara A, Daffaud F,et al.Individual dose adjustment of high-dose methotrexate in clinical practice[J]. Revue de Medicine Interne,1996,17(8):689 被引量：1
8Balis F M,Blaney S M, Mccully C L,et al. Methotrexate distribution within the subarachnoid space after intraventricular and intravenous administration [ J ]. Cancer Chemoth Pharm ,2000,45 ( 3 ) :259-264. 被引量：1
9Murakami Y, Yamazaki K, Sakauchi N, et al. A one-month repeated oral does toxicity study of methotrexate in unilatc rally nephrectomized rats [ J ]. J Toxicol Sci, 1998,23 ( 5 ) : 681-699. 被引量：1
10Shibayama Y, Takeda Y, Yamada K. Effect of methotrexate treatment on expression levels of oragnic anion transporter polypeptide 2, P-glycoproein and bile salt export pump in rats [ J]. Biol Pharm Bull, 2009,32 (3) :493-496. 被引量：1
